CASTER: Cross-Sectional Asthma STEroid Response Measurement

Area of Science:

• Pharmacogenetics
• Respiratory Medicine
• Clinical Trial Analysis

Background:

• Variability in asthma patient response to inhaled corticosteroids (ICS) complicates treatment assessment.
• Quantifying steroid response is crucial for pharmacogenetic research but current methods are limited.
• Need for a reliable measure applicable to both longitudinal and cross-sectional asthma studies.

Purpose of the Study:

• To define a robust measure for assessing inhaled corticosteroid (ICS) response in asthma.
• To develop a steroid response measure suitable for pharmacogenetic research across diverse asthma cohorts.
• To validate the new measure using cross-sectional data from multiple independent asthma studies.

Main Methods:

• Utilized longitudinal data from the Childhood Asthma Management Program (CAMP) cohort.
• Defined the Cross-sectional Asthma STEroid Response (CASTER) measure using CAMP cross-sectional data.
• Applied and validated CASTER on cross-sectional data from four independent asthma cohorts (IMPACT, SOCS, PACT, GACRS).

Main Results:

• The CASTER measure demonstrated high accuracy in identifying steroid responders across childhood asthma cohorts.
• Achieved significant Area Under the Curve (AUC) values: 82% (GACRS), 71% (PACT), and 63% (CAMP cross-sectional).
• Indicated that cross-sectional clinical data can effectively identify ICS treatment responders in pediatric asthma.

Conclusions:

• The CASTER measure provides an accurate and practical method for assessing inhaled corticosteroid response in asthma.
• CASTER significantly enhances the usability and applicability of steroid response measures in asthma research.
• This measure facilitates pharmacogenetic studies by enabling reliable classification of steroid responders.